Ed Rosenthal – Trademark Portfolio

Entity Type: 01

Ed Rosenthal holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ASK ED. The owner is based in Sunnyvale, CA.

162 N. WOLFE ROAD

Sunnyvale, CA 94086

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ed Rosenthal's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

6
Metal Goods (1 filing)

Common metals and their alloys; metal building materials; transportable buildings of metal

Frequently Asked Questions

How many trademarks does Ed Rosenthal have?

Ed Rosenthal has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does Ed Rosenthal file in?

Ed Rosenthal files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 44 (Medical Services), Class 6 (Metal Goods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Ed Rosenthal's most well-known trademarks?

Ed Rosenthal's registered trademark portfolio includes well-known marks such as ASK ED. These are among 1 currently registered trademark in the portfolio.

What is Ed Rosenthal's trademark registration success rate?

Ed Rosenthal has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.